汉中高一学校正规排名(秦都区中考冲刺实力效果好) (今日更新中)

The woman had used oxycodone for almost a decade but told her doctors she had been sober for two years. She never touched narcotics during her pregnancy, she said, and had completed rehab.But her newborn son was in withdrawal: jittery, screaming and requiring an infusion of morphine to stay alive. The infant craved drugs, but why?Amid an opioid epidemic, the boy's doctors didn't blame heroin, fentanyl or other illicit substances. Instead, they said, the infant had grown dependent on a controversial herbal supplement: kratom. 538

The top U.S. public health agency stirred confusion by posting — and then taking down — an apparent change in its position on how easily the coronavirus can spread from person to person through the air.But officials at the Centers for Disease Control and Prevention say their position has not really changed and that the post last week on the agency’s website was an error that has been taken down.It was “an honest mistake” that happened when a draft update was posted before going through a full editing and approval process, said Dr. Jay Butler, the CDC’s deputy director for infectious diseases.The post suggested that the agency believes the virus can hang in the air and spread over an extended distance. But the agency continues to believe larger and heavier droplets that come from coughing or sneezing are the primary means of transmission, Butler said.Most CDC guidance about social distancing is built around that idea, saying that about 6 feet is a safe buffer between people who are not wearing masks.In interviews, CDC officials have acknowledged growing evidence that the virus can sometimes be transmitted on even smaller, aerosolized particles or droplets that spread over a wider area. Certain case clusters have been tied to events in which the virus appeared to have spread through the air in, for example, a choir practice. But such incidents did not appear to be common.Public health experts urge people to wear masks, which can stop or reduce contact with both larger droplets and aerosolized particles.But for months, agency officials said little about aerosolized particles. So when the CDC quietly posted an update Friday that discussed the particles in more detail, the agency’s position appeared to have changed. The post said the virus can remain suspended in the air and drift more than 6 feet. It also emphasized the importance of indoor ventilation and seemed to describe the coronavirus as the kind of germ that can spread widely through the air.The post caused widespread discussion in public health circles because of its implications. It could mean, for example, that hospitals might have to place infected people in rooms that are specially designed to prevent air from flowing to other parts of the hospital.But the CDC is not advising any changes in how far people stay away from each other, how they are housed at hospitals or other measures, Butler said.The CDC has come under attack for past revisions of guidance during the pandemic, some of which were driven by political pressure by the Trump administration.Butler said there was no external political pressure behind the change in this instance. “This was an internal issue,. And we’re working hard to address it and make sure it doesn’t happen again,” he said.In a statement released Monday, the CDC said the revisions to the “How COVID-19 Spreads” page happened “without appropriate in-house technical review.”“We are reviewing our process and tightening criteria for review of all guidance and updates before they are posted to the CDC website,” the statement said.At least one expert said the episode could further chip away at public confidence in the CDC.“The consistent inconsistency in this administration’s guidance on COVID-19 has severely compromised the nation’s trust in our public health agencies,” said Dr. Howard Koh, a Harvard University public health professor who was a high-ranking official in the Department of Health and Human Services during the Obama administration.“To rectify the latest challenge, the CDC must acknowledge that growing scientific evidence indicates the importance of airborne transmission through aerosols, making mask wearing even more critical as we head into the difficult fall and winter season,” Koh said in a statement.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 3964

The US Food and Drug Administration expanded?the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.New to the list are some valsartan products manufactured by Hetero Labs Ltd. in India, which are labeled as Camber Pharmaceuticals Inc. Test results show that some of the products may be tainted.The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were affected.N-nitrosodimethylamine or NDMA, the impurity the lab tests found, is considered a?possible carcinogen by the US Environmental Protection Agency. It is an organic chemical that has been used to make liquid rocket fuel, and it can be unintentionally introduced through certain chemical reactions. It's a byproduct of the manufacturing of some pesticides and fish processing.The medicines that are now a part of this expanded list?in the recall are tablets sold by AvKare, A-S Medication Solutions LLC, Bryant Ranch Prepack Inc, Camber Pharmaceuticals, Inc. H J Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (labeled as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis).The FDA also published a list of valsartan products that are not currently recalled. Only the drugs suspected of being tainted with NDMA are on the recall list. If you are taking a valsartan drug, look for the company name on your prescription bottle. If the information isn't on the label, you can call your pharmacy for those details.The recalled medicine is linked to a manufacturer in China. The substances were supplied by Zhejiang Huahai Pharmaceuticals, based in Linhai, in eastern China, which said it notified authorities as soon as it identified the impurity."We published our recall notice at midday on July 13 in China and overseas, and published the US market recall notice on July 14 Beijing time ... all the drug materials for the Chinese market were recalled by July 23," the company said in a statement to the Shanghai stock exchange last month.The FDA said on its website that it's working with drug manufacturers "to ensure future valsartan active pharmaceutical ingredients are not at risk."If you are worried that your drug could be on the recall list, talk with your doctor or pharmacist before changing any routine with your medicine. Because not all valsartan drugs are involved in the recall, they might be able to switch you to a version of the drug made by another company.If you know your drug is on the recall list, the FDA suggests you continue taking it until your doctor or pharmacist provides a replacement.To get a sense of what taking a tainted drug could mean, FDA scientists estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) from the recalled batches every day for four years, there may be one additional case of cancer."The key with this is, patients should not stop taking their medication abruptly, that definitely can be harmful," Dr. Mary Ann Bauman, a representative for the American Heart Association, said in July. "You don't want to jump to any conclusions on your own about this medication, or any medication for that matter. Definitely talk with your doctor first." 3690

The sheriff's sergeant who initially responded to last month's mass shooting at the Borderline Bar and Grill in Thousand Oaks, California, was fatally shot by gunfire from a California Highway Patrol officer, officials said Friday.Sgt. Ron Helus was struck five times by gunfire from the suspect, Ian David Long, according to Ventura County Sheriff Bill Ayub, but was hit by a sixth bullet from a CHP officer's rifle.Helus could have potentially survived the five wounds from Long's weapon, but the sixth bullet proved fatal. It struck Helus in the chest and his heart, according to Dr. Christopher Young, the Ventura County medical examiner. It was the "most lethal wound" Helus sustained, Young said.The 29-year law enforcement veteran was set to retire from the Ventura County Sheriff's Office next year. He was among the first officers through the door at the Borderline when the shooting began November 8 and was shot as he tried to stop the gunman, who killed 11 others in the attack.Helus later died at a hospital. 1029

The Trump administration plans to announce the long-anticipated federal rule officially banning bump stocks in the coming days, according to US officials familiar with the matter.Bump stocks gained national attention last year after a gunman in Las Vegas rigged his weapons with the devices to fire on concertgoers, killing 58 people. President Donald Trump vowed to outlaw the devices soon after the tragedy, and some lawmakers on Capitol Hill urged him to back a permanent legislative fix.But opposition from lawmakers and the National Rifle Association ultimately made a regulatory change the only realistic path forward to accomplishing the President's goal.The devices make it easier to fire rounds from a semi-automatic weapon by harnessing the gun's recoil to "bump" the trigger faster -- an operation that caused officials at the Bureau of Alcohol, Tobacco, Firearms and Explosives during the Obama administration to conclude that it's merely a gun accessory or firearm part, not subject to federal regulation.At Trump's direction, however, the Justice Department submitted a proposed final rule earlier this year that upended the Obama-era interpretation, and concluded that bump-fire stocks, "slide-fire" devices, and devices with certain similar characteristics all fall within the prohibition on machine guns by allowing a "shooter of a semiautomatic firearm to initiate a continuous firing cycle with a single pull of the trigger," and therefore, they are illegal under federal law.Under the new rule, bump stock owners would be required to destroy or surrender the devices to authorities. Members of the public will be given 90 days to turn in or otherwise discard their bump stocks, according to a source familiar with the final rule."Bump stocks turn semiautomatic guns into illegal machine guns. This final rule sends a clear message: Illegal guns have no place in a law-and-order society, and we will continue to vigorously enforce the law to keep these illegal weapons off the street," a senior Justice Department official told CNN Wednesday.Republican lawmakers, who are typically opposed to federal agencies writing regulations to accomplish what Congress hasn't directly legislated, had insisted that the Justice Department and ATF write a new regulation. Whereas some Democrats, such as Sen. Dianne Feinstein of California, have repeatedly cautioned that such a ban would likely result in lawsuits given ATF's earlier interpretation.ATF Acting Director Thomas Brandon acknowledged in a Senate hearing this summer that he has been advised that banning bump fire stocks through executive regulation could lead to court challenges that would delay the implementation of a ban.Trump said last month he told the NRA "bump stocks are gone," but how the group responds to the final rule remains to be seen. A spokesperson for the NRA said in October 2017 that the ATF "should review bump-fire stocks to ensure they comply with federal law," but made clear it opposed the broader gun-control legislation raised by some in Congress.In June, Slide Fire Solutions, the Texas company that invented the bump-fire stock device and was its lead manufacturer, announced on its website that it would stop taking orders for its products and would shut down its website.The company, however, directs buyers to RW Arms, an arms dealer also based in Texas, which appears to be selling the remainder of Slide Fire's inventory. RW Arms was advertising for bump fire stocks made by Slide Fire as recently as this week, when they offered a Cyber Monday sale on the product. Slide Fire has not responded to repeated requests for comment about any potential litigation over a federal rule banning bump stocks.The-CNN-Wire 3725

来源：资阳报